Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism

Clinical Nephrology

Volumn 74, Issue 3, 2010, Pages 182-189

  Koch, M ^a   Aker, S ^a   Haastert, B ^b   Rump, L C ^c  

^a and Metabolic Diseases   (Germany)

^b Medistatistica   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aldosterone; Aldosterone to renin ratio; Hypertension; Natriuresis; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN; ANTIHYPERTENSIVE AGENT; SODIUM INTAKE;

ADULT; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CREATININE CLEARANCE; DATA ANALYSIS; DIETARY INTAKE; EVALUATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; PRIMARY HYPERALDOSTERONISM; SALT INTAKE; SCREENING; ADMINISTRATION AND DOSAGE; AGE; BLOOD; CROSS-SECTIONAL STUDY; DRUG EFFECTS; HYPERALDOSTERONISM; MIDDLE AGED; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE;

AGE FACTORS; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM, DIETARY;

EID: 77957102904     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74182     Document Type: Article

References (24)

1. Reincke, M, Seiler, L, Rump LC. Normokaliämischer primärer Hyperaldosteronismus. Dtsch Ärztebl. 2003; 100: 184-190.
2. Rossi GP. Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue? Curr Hypertens Rep. 2004; 6: 1-4.
3. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007; 66: 607-618.
4. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem. 2005; 51: 386-394.
5. Montori VM, Young WF, Jr. Use of plasma aldosterone concentration-to- plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am. 2002; 31: 619-632.
6. Pilz S, Tomaschitz A, Stepan V, Obermayer-Pietsch B, Fahrleitner-Pammer A, Schweighofer N, Portugaller HR, Sourij H, Dobnig H,Meinitzer A, Pieber TR. Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism. BMC Endocr Disord. 2009; 9: 11.
7. Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, Stewart PM. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab. 2005; 16: 114-119.
8. Diederich S, Bidlingmaier M, Quinkler M, Reincke M. Diagnosis of primary hyperaldosteronism. Med Klin (Munich). 2007; 102: 16-21.
9. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Jr, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93: 3266-3281.
10. Schirpenbach C, Segmiller F, Diederich S, Hahner S, Lorenz R, Rump LC, Seufert J, Quinkler M, Bidlingmaier M, Beuschlein F, Endres S, Reincke M. The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Ärztebl Int. 2009; 106: 305-311.
11. Stowasser M, Gordon RD. Primary aldosteronism. Best Pract Res Clin Endocrinol Metab. 2003; 17: 591-605.
12. Rossi GP, Seccia TM, Pessina AC. Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol. 2008; 21: 447-454.
13. Le CT. Introductory Biostatistics. Hoboken, NJ: John Wiley & Sons, Inc.; 2003.
14. Luft FC, Fineberg NS, Sloan RS. Overnight urine collections to estimate sodium intake. Hypertension. 1982; 4: 494-498.
15. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW, Vidt DG. The changing clinical spectrum of primary aldosteronism. Am J Med. 1983; 74: 641-651.
16. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002; 40: 897-902.
17. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F. Aprospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006; 48: 2293-2300.
18. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001; 2: 156-169.
19. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001; 37: 699-705.
20. Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab. 2001; 86: 4292-4298.
21. Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf). 2002; 57: 457-465.
22. Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, Corgnati A, Falcone S, Corrocher R, Micchi A, Cressoni C, Blengio G. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab. 2004; 89: 4221-4226.
23. James GD, Sealey JE, Muller F, Alderman M, Madhavan S, Laragh JH. Renin relationship to sex, race and age in a normotensive population. J Hypertens. 1986; 4 (Suppl.): 387-389.
24. Tsunoda K, Abe K, Goto T, Yasujima M, Sato M, Omata K, Seino M, Yoshinaga K. Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma. J Clin Endocrinol Metab. 1986; 62: 384-389.